CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,901,610 | -4.4% | 639,226 | -1.6% | 0.01% | 0.0% |
| Q1 2024 | $10,352,073 | +6.5% | 649,440 | +12.3% | 0.01% | 0.0% |
| Q4 2023 | $9,721,342 | +43.9% | 578,307 | +0.1% | 0.01% | +20.0% |
| Q3 2023 | $6,754,821 | -13.5% | 577,829 | -0.5% | 0.01% | 0.0% |
| Q2 2023 | $7,808,505 | -23.2% | 580,990 | -5.3% | 0.01% | -28.6% |
| Q1 2023 | $10,171,813 | -13.5% | 613,499 | -2.9% | 0.01% | -22.2% |
| Q4 2022 | $11,755,683 | +50.7% | 632,026 | +3.9% | 0.01% | +50.0% |
| Q3 2022 | $7,803,000 | +1424.0% | 608,167 | +733.2% | 0.01% | – |
| Q2 2022 | $512,000 | -21.6% | 72,996 | -7.4% | 0.00% | – |
| Q1 2022 | $653,000 | -18.7% | 78,804 | -33.6% | 0.00% | – |
| Q4 2021 | $803,000 | +1154.7% | 118,680 | +959.2% | 0.00% | – |
| Q2 2021 | $64,000 | -32.6% | 11,205 | -45.9% | 0.00% | – |
| Q1 2021 | $95,000 | +9.2% | 20,701 | -20.6% | 0.00% | – |
| Q4 2020 | $87,000 | -18.7% | 26,082 | -27.9% | 0.00% | – |
| Q3 2020 | $107,000 | -39.2% | 36,188 | -4.9% | 0.00% | – |
| Q2 2020 | $176,000 | +66.0% | 38,038 | +38.2% | 0.00% | – |
| Q1 2020 | $106,000 | +1.0% | 27,521 | -2.0% | 0.00% | – |
| Q4 2019 | $105,000 | -33.5% | 28,088 | -5.7% | 0.00% | – |
| Q3 2019 | $158,000 | +47.7% | 29,801 | +7.6% | 0.00% | – |
| Q2 2019 | $107,000 | +62.1% | 27,697 | +113.1% | 0.00% | – |
| Q1 2019 | $66,000 | +135.7% | 12,997 | -12.0% | 0.00% | – |
| Q4 2018 | $28,000 | -59.4% | 14,763 | -19.7% | 0.00% | – |
| Q3 2018 | $69,000 | +53.3% | 18,378 | +27.7% | 0.00% | – |
| Q2 2018 | $45,000 | +2.3% | 14,387 | +28.2% | 0.00% | – |
| Q4 2017 | $44,000 | +57.1% | 11,220 | 0.0% | 0.00% | – |
| Q3 2017 | $28,000 | -22.2% | 11,220 | -14.3% | 0.00% | – |
| Q2 2017 | $36,000 | +140.0% | 13,094 | +2.7% | 0.00% | – |
| Q1 2016 | $15,000 | -51.6% | 12,745 | 0.0% | 0.00% | – |
| Q4 2015 | $31,000 | -18.4% | 12,745 | 0.0% | 0.00% | – |
| Q3 2015 | $38,000 | – | 12,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |